We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
The Zacks Analyst Blog Highlights SAP, Elevance Health, Diageo, SLB and Charter Communications
Read MoreHide Full Article
For Immediate Release
Chicago, IL – April 3, 2023 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: SAP SE (SAP - Free Report) , Elevance Health, Inc. (ELV - Free Report) , Diageo plc (DEO - Free Report) , SLB Ltd. (SLB - Free Report) and Charter Communications, Inc. (CHTR - Free Report) .
Here are highlights from Friday’s Analyst Blog:
Top Analyst Reports for SAP, Elevance Health and Diageo
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including SAP SE, Elevance Health, Inc. and Diageo plc. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
Shares of SAP have outperformed the Zacks Computer - Software industry over the past year (+13.9% vs. -6.1%), reflecting momentum in its cloud business (especially the new Rise with SAP solution) across all regions.
Momentum in SAP’s business technology platform particularly the S/4HANA solutions augurs well. The company’s restructuring plan is expected to better align its operating models and go-to-market approach with its accelerated cloud transformation. Frequent product launches like SAP Build and strategic collaborations bodes well.
However, the company’s performance is affected due to continued softness in software licenses and support business segments coupled with supply chain constraints, global macroeconomic weakness and geopolitical instability. Also, increasing research & development and sales & marketing expenses coupled with stiff competition in the cloud space are concerns.
Shares of Elevance Health have declined -8.1% over the past year against the Zacks Medical Services industry’s decline of -29.7%.
While margins pressures and a relatively debt-heavy balance sheet are causes for concern, Elevance Health is benefiting from improving top line on the back of premium rate increases and higher memberships. Acquisitions, collaborations and product expansions have enabled the company to strengthen its business portfolio.
Its well-performing Medicare and Medicaid businesses, coupled with several contract wins, are expected to drive its membership going ahead. Growing premiums, stemming from rate increases are aiding the company's results. Elevance Health utilizes excess capital to boost shareholder value.
Shares of Diageo have gained +6.8% over the past six months against the Zacks Beverages - Alcohol industry’s gain of +10.3%. The company’s robust sales growth, organic operating margin expansion, productivity savings and favorable currency impact aided first-half fiscal 2023 results. Effective marketing and exceptional commercial execution further aided the results.
Price/mix gained from a positive mix due to the robust growth in super-premium-plus brands, particularly scotch, tequila and Chinese white spirits. DEO’s margin trends were favorable in the first half, thanks to its premiumization efforts, recovery in markets, pricing actions and supply productivity savings, which mostly offset the cost inflation.
The company retained its optimistic view for the medium to long term. However, inflationary pressures from higher glass, ocean freight and other transportation costs, and currency headwinds are concerning.
Other noteworthy reports we are featuring today include SLB Ltd. and Charter Communications, Inc.
Why Haven’t You Looked at Zacks' Top Stocks?
Since 2000, our top stock-picking strategies have blown away the S&P's +6.2 average gain per year. Amazingly, they soared with average gains of +46.4%, +49.5% and +55.2% per year. Today you can access their live picks without cost or obligation.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
The Zacks Analyst Blog Highlights SAP, Elevance Health, Diageo, SLB and Charter Communications
For Immediate Release
Chicago, IL – April 3, 2023 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: SAP SE (SAP - Free Report) , Elevance Health, Inc. (ELV - Free Report) , Diageo plc (DEO - Free Report) , SLB Ltd. (SLB - Free Report) and Charter Communications, Inc. (CHTR - Free Report) .
Here are highlights from Friday’s Analyst Blog:
Top Analyst Reports for SAP, Elevance Health and Diageo
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including SAP SE, Elevance Health, Inc. and Diageo plc. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
You can see all of today’s research reports here >>>
Shares of SAP have outperformed the Zacks Computer - Software industry over the past year (+13.9% vs. -6.1%), reflecting momentum in its cloud business (especially the new Rise with SAP solution) across all regions.
Momentum in SAP’s business technology platform particularly the S/4HANA solutions augurs well. The company’s restructuring plan is expected to better align its operating models and go-to-market approach with its accelerated cloud transformation. Frequent product launches like SAP Build and strategic collaborations bodes well.
However, the company’s performance is affected due to continued softness in software licenses and support business segments coupled with supply chain constraints, global macroeconomic weakness and geopolitical instability. Also, increasing research & development and sales & marketing expenses coupled with stiff competition in the cloud space are concerns.
(You can read the full research report on SAP here >>>)
Shares of Elevance Health have declined -8.1% over the past year against the Zacks Medical Services industry’s decline of -29.7%.
While margins pressures and a relatively debt-heavy balance sheet are causes for concern, Elevance Health is benefiting from improving top line on the back of premium rate increases and higher memberships. Acquisitions, collaborations and product expansions have enabled the company to strengthen its business portfolio.
Its well-performing Medicare and Medicaid businesses, coupled with several contract wins, are expected to drive its membership going ahead. Growing premiums, stemming from rate increases are aiding the company's results. Elevance Health utilizes excess capital to boost shareholder value.
(You can read the full research report on Elevance Health here >>>)
Shares of Diageo have gained +6.8% over the past six months against the Zacks Beverages - Alcohol industry’s gain of +10.3%. The company’s robust sales growth, organic operating margin expansion, productivity savings and favorable currency impact aided first-half fiscal 2023 results. Effective marketing and exceptional commercial execution further aided the results.
Price/mix gained from a positive mix due to the robust growth in super-premium-plus brands, particularly scotch, tequila and Chinese white spirits. DEO’s margin trends were favorable in the first half, thanks to its premiumization efforts, recovery in markets, pricing actions and supply productivity savings, which mostly offset the cost inflation.
The company retained its optimistic view for the medium to long term. However, inflationary pressures from higher glass, ocean freight and other transportation costs, and currency headwinds are concerning.
(You can read the full research report on Diageo here >>>)
Other noteworthy reports we are featuring today include SLB Ltd. and Charter Communications, Inc.
Why Haven’t You Looked at Zacks' Top Stocks?
Since 2000, our top stock-picking strategies have blown away the S&P's +6.2 average gain per year. Amazingly, they soared with average gains of +46.4%, +49.5% and +55.2% per year. Today you can access their live picks without cost or obligation.
See Stocks Free >>
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
support@zacks.com
https://www.zacks.com
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.